Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …

Background Prostate-specific membrane antigen (PSMA) PET is highly sensitive in
identifying disease recurrence in men with biochemical recurrence of prostate cancer (BCR) …

Prostate-specific membrane antigen (PSMA)–targeted PET imaging recently emerged as a
new method for the staging and restaging of prostate cancer. Most published studies …

The use of prostate-specific membrane antigen (PSMA)-directed applications in modern
prostate cancer management has evolved rapidly over the past few years, helping to …

Radiotherapy and radiation oncology play a key role in the clinical management of patients
suffering from oncological diseases. In clinical routine, anatomic imaging such as contrast …

Abstract Recently, 68 Ga-labeled prostate-specific membrane antigen (PSMA)–ligand
positron-emission tomography (PET) imaging has been shown to improve detection rates in …

68Ga-labeled prostate-specific membrane antigen (PSMA) PET/CT is increasingly used in
men with biochemical recurrence (BCR) after radical prostatectomy (RP), but its longer-term …

Over 90% of prostate cancers over-express prostate specific membrane antigen (PSMA) and
these tumor cells may be accurately targeted for diagnosis by 68Ga-PSMA-positron …

Objectives To review the literature to determine the sensitivity and specificity of gallium‐68
prostate‐specific membrane antigen (68Ga‐PSMA) positron‐emission tomography (PET) for …

Purpose The primary aim of this retrospective, single-centre analysis was to assess the
performance of 68 Ga-PSMA-11 PET/CT in prostate cancer (PCa) patients in early PSA …